Skip to content
Independent analysis of NHS open data
PharmaInsight

Emtricitabine/Rilpivirine/Tenofovir alafenamide

Infections Antiviral drugs BNF 0503010BC
Data updated April 2026 Download CSV
1items

Dispensed in April 2026

3items

Rolling 12 months

£491

Net ingredient cost · April 2026

Figure 1. Emtricitabine/Rilpivirine/Tenofovir alafenamide: national items dispensed by month

0 1 2 Jan 2026 Apr 2026 1 Jan 2026: 2 Apr 2026: 1

Source: NHSBSA Prescription Cost Analysis, to April 2026

Download CSV
Embed this chart

Free to reuse with the credit line above.

At a glance

  • Therapeutic class Antiviral drugs
  • Presentations 1 shown
  • Average cost / item £490.89
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, April 2026

The individual products dispensed under Emtricitabine/Rilpivirine/Tenofovir alafenamide this month.

Presentations of Emtricitabine/Rilpivirine/Tenofovir alafenamide, April 2026
Presentation BNF code Items Net ingredient cost
Odefsey 200mg/25mg/25mg tablets 0503010BCBBAAAA 1 £491

Source: NHSBSA Prescription Cost Analysis · to April 2026 OGL v3.0

Where Emtricitabine/Rilpivirine/Tenofovir alafenamide is dispensed

The regions and dispensing practices with the highest Emtricitabine/Rilpivirine/Tenofovir alafenamide volumes.

Top dispensing practices

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Emtricitabine/Rilpivirine/Tenofovir alafenamide with

Other medicines in the same BNF section, by prescribing volume.

Download this data

The monthly series for Emtricitabine/Rilpivirine/Tenofovir alafenamide is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.